Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.Cochrane Database Syst Rev. 2021; 7CD013656
- Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial.Can J Urol. 2020; 27: 10072-10079
Zorn KC, Bidair M, Trainer A, et al. Aquablation therapy in large prostates (80–150 cc) for lower urinary tract symptoms due to benign prostatic hyperplasia: WATER II 3-year trial results. BJUI Compass Available at: https://onlinelibrary.wiley.com/doi/abs/10.1002/bco2.121, Accessed November 15, 2021.
- First multi-center all-comers study for the aquablation procedure.J Clin Med. 2020; 9 (PMID: 32102329; PMCID: PMC7073705): 603https://doi.org/10.3390/jcm9020603
- Waterjet ablation therapy for treating benign prostatic obstruction in patients with small- to medium-size glands: 12-month results of the first french aquablation clinical registry.Eur Urol. 2019; 76: 667-675
- Meta-analysis with individual data of functional outcomes following Aquablation for lower urinary tract symptoms due to BPH in various prostate anatomies.BMJ Surg Interv Health Technologies. 2021; 3e000090
- WATER: a double-blind, randomized, controlled trial of aquablation® vs transurethral resection of the prostate in benign prostatic hyperplasia.J Urol. 2018; 199: 1252-1261
- Five-year outcomes for Aquablation therapy compared to TURP: results from a double-blind, randomized trial in men with LUTS due to BPH.Can J Urol. 2022; 29: 10960-10968
- Cavitating jet: a review.Appl Sci. 2020; 10: 7280
- Transfusion rates after 800 aquablation procedures using various hemostasis methods.BJU Int. 2020; 125 (Epub 2020 Jan 24. PMID: 31901210; PMCID: PMC7187336): 568-572https://doi.org/10.1111/bju.14990
- Focal bladder neck cautery associated with low rate of post-Aquablation bleeding.Can J Urol. 2021; 28: 10610-10613
Financial Disclosure: The clinical studies were funded by PROCEPT BioRobotics. Thorsten Bach, Neil Barber, Dean Elterman, Naeem Bhojani, Kevin C. Zorn, and Alexis Te have had in the past or currently have a consulting agreement with PROCEPT BioRobotics. Mitch Humphreys, Bilal Chugtai, and Steven Kaplan have no disclosures with PROCEPT BioRobotics. Thorsten Bach led the manuscript effort and analysis. The remaining authors on the manuscript were involved with recruiting, treating patients, data collection, and manuscript review.